IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients Induction therapy: • liposomal AmB (3–4 mg/kg per day) 2 weeks or • ABLC (5 mg/kg per day) plus flucytosine (100 mg/kg per day) 2 weeks Alternatives for induction therapy: • Liposomal AmB (6 mg/kg per day) or ABLC (5 mg/kg per day) 4–6 weeks • AmBd (0.7 mg/kg per day) 4–6 weeks Consolidation therapy: fluconazole (400–800 mg per day) 8 weeks B-III Maintenance therapy: fluconazole (200–400 mg per day) 6 months to 1 year B-III #Cryptococcal #Meningoencephalitis #IDSA #Treatment #management #meningitis #cryptococcus #transplant
